Dr. Emily Daniel, MD

Dr. Daniel practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Daniel's NPI, 1710333786, was assigned on May 10, 2016. Dr. Daniel holds Maryland license D95209.

Dr. Daniel's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Daniel's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Daniel is also affiliated with University of Maryland Rehabilitation & Orthopaedic Institute. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology. Dmand AI also links Dr. Daniel to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daniel practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Daniel's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Daniel is licensed in Maryland.

CMS data shows 1,120 Medicare services from Dr. Daniel across 6 procedure codes in 2024, for 247 Medicare patients. Medicare paid $104,112 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 247 Medicare patients who saw Dr. Daniel in 2024. The largest group is under 65, with 126 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 7.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Daniel's median patient age at 61, with 43% women.

In 2024, Dr. Daniel wrote 575 Medicare Part D claims for 70 patients. 98% of them were for generic drugs. CMS names the drug for 472 of them, across 20 drugs with 11 or more claims each, at $18,123 in total drug cost. In 2023, CMS named 48 claims across 4 drugs.

Dr. Daniel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Daniel from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $39.